Skip to main content
Top
Published in: Head and Neck Pathology 4/2014

01-12-2014 | Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Metastatic Tumors to the Jaws and Mouth

Authors: Abraham Hirshberg, Raanan Berger, Irit Allon, Ilana Kaplan

Published in: Head and Neck Pathology | Issue 4/2014

Login to get access

Abstract

Metastatic dissemination to the oral cavity is rare and is usually the evidence of a wide spread disease with an average survival rate of 7 months. In almost a quarter of the cases, oral metastasis was found to be the first indication of an occult malignancy at a distant site. Metastatic lesions can be found anywhere in the oral cavity, however, the jawbones with the molar area is the most frequently involved site. In the oral soft tissues, the gingiva is the most common site, suggesting the possible role of inflammation in the attraction of metastatic deposits. The most common primary malignancies presenting oral metastases were the lung, kidney, liver, and prostate for men, and breast, female genital organs, kidney, and colo-rectum for women. Most patients with jawbone metastasis complain of swelling, pain, and paresthesia. An exophytic lesion is the most common clinical presentation of metastatic lesions in the oral soft tissues. Early lesions, mainly those located in the gingiva, may resemble a hyperplastic or reactive lesion. Once a lesion is recognized as metastasis, the primary tumor site should be identified following clinical, radiological and histopathological investigations. If standardized diagnostic workup fails to detect the site of origin, then the term carcinoma of unknown primary is applied. Personalized medicine tools such as tissue-of-origin assays should be applied, either by immunohistochemical testing or by molecular-profiling methods as these may lead to a more favorable outcome.
Literature
2.
go back to reference Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef
3.
4.
go back to reference Servato JP, de Paulo LF, de Faria PR, Cardoso SV, Loyola AM. Metastatic tumours to the head and neck: retrospective analysis from a Brazilian tertiary referral centre. Int J Oral Maxillofac Surg. 2013;42(11):1391–6.PubMedCrossRef Servato JP, de Paulo LF, de Faria PR, Cardoso SV, Loyola AM. Metastatic tumours to the head and neck: retrospective analysis from a Brazilian tertiary referral centre. Int J Oral Maxillofac Surg. 2013;42(11):1391–6.PubMedCrossRef
5.
go back to reference Hashimoto N, Kurihara K, Yamasaki H, Ohba S, Sakai H, Yoshida S. Pathological characteristics of metastatic carcinoma in the human mandible. J Oral Pathol. 1987;16(7):362–7.PubMedCrossRef Hashimoto N, Kurihara K, Yamasaki H, Ohba S, Sakai H, Yoshida S. Pathological characteristics of metastatic carcinoma in the human mandible. J Oral Pathol. 1987;16(7):362–7.PubMedCrossRef
6.
go back to reference Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. 1993;22(9):385–90.PubMedCrossRef Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. 1993;22(9):385–90.PubMedCrossRef
7.
go back to reference Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jaws: analysis of 390 cases. J Oral Pathol Med. 1994;23(8):337–41.PubMedCrossRef Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jaws: analysis of 390 cases. J Oral Pathol Med. 1994;23(8):337–41.PubMedCrossRef
8.
go back to reference Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Oral Oncol. Eur J Cancer. 1995;31B(6):355–60.CrossRef Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Oral Oncol. Eur J Cancer. 1995;31B(6):355–60.CrossRef
9.
go back to reference Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.PubMedCrossRef Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.PubMedCrossRef
10.
go back to reference Allon I, Pessing A, Kaplan I, Allon DM, Hirshberg A. Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis. J Periodontol. 2014;85(1):132–9.PubMedCrossRef Allon I, Pessing A, Kaplan I, Allon DM, Hirshberg A. Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis. J Periodontol. 2014;85(1):132–9.PubMedCrossRef
12.
go back to reference Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539–44.PubMedCrossRef Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539–44.PubMedCrossRef
13.
go back to reference Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010;2(25):25.CrossRef Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010;2(25):25.CrossRef
14.
go back to reference Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011;128(11):2511–26.PubMedCrossRef Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011;128(11):2511–26.PubMedCrossRef
18.
go back to reference Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.PubMedCrossRef Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.PubMedCrossRef
20.
go back to reference Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 Suppl 16):15–8.PubMedCrossRef Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 Suppl 16):15–8.PubMedCrossRef
21.
go back to reference Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359–70.PubMedCrossRef Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359–70.PubMedCrossRef
23.
go back to reference Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677–84.PubMedCrossRef Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677–84.PubMedCrossRef
24.
go back to reference Reymond N, d’Água BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13(12):858–70.PubMedCrossRef Reymond N, d’Água BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13(12):858–70.PubMedCrossRef
25.
go back to reference Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef
26.
go back to reference Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–3.CrossRef Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–3.CrossRef
28.
go back to reference Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72(11):1605–21.PubMedCrossRef Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72(11):1605–21.PubMedCrossRef
29.
go back to reference Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29(4):381–95.PubMedCrossRef Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29(4):381–95.PubMedCrossRef
30.
go back to reference Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis–tracing the accessory. Oncogene. 2014;33(25):3217–24.PubMedCrossRef Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis–tracing the accessory. Oncogene. 2014;33(25):3217–24.PubMedCrossRef
31.
go back to reference Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71.PubMedCrossRef Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71.PubMedCrossRef
32.
go back to reference Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139–46.PubMedCrossRef Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139–46.PubMedCrossRef
33.
go back to reference Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.PubMedCentralPubMedCrossRef Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.PubMedCentralPubMedCrossRef
34.
go back to reference Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.PubMedCentralPubMedCrossRef Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.PubMedCentralPubMedCrossRef
35.
go back to reference Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49(9):887–92.PubMedCrossRef Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49(9):887–92.PubMedCrossRef
36.
go back to reference Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2406–12.PubMedCrossRef Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2406–12.PubMedCrossRef
37.
38.
go back to reference Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRef Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRef
39.
go back to reference Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012;4:87–93.PubMedCentralPubMed Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012;4:87–93.PubMedCentralPubMed
40.
go back to reference Rahim F, Hajizamani S, Mortaz E, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res. 2014;2014:405920.PubMedCentralPubMedCrossRef Rahim F, Hajizamani S, Mortaz E, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res. 2014;2014:405920.PubMedCentralPubMedCrossRef
41.
go back to reference Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97(1):59–69.PubMedCrossRef Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97(1):59–69.PubMedCrossRef
42.
go back to reference Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2011;18(2):326–35.PubMedCrossRef Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2011;18(2):326–35.PubMedCrossRef
43.
go back to reference Rucci N, Teti A. Osteomimicry: how tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2010;1(2):907–15.CrossRef Rucci N, Teti A. Osteomimicry: how tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2010;1(2):907–15.CrossRef
44.
go back to reference Clezardin P, Teti A. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis. 2007;24(8):599–608.PubMedCrossRef Clezardin P, Teti A. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis. 2007;24(8):599–608.PubMedCrossRef
47.
go back to reference Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol. 2014;11(6):335–45.PubMedCrossRef Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol. 2014;11(6):335–45.PubMedCrossRef
48.
go back to reference Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Prostate. 2004;58(4):406–13.PubMedCrossRef Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Prostate. 2004;58(4):406–13.PubMedCrossRef
49.
go back to reference Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta. 2014;1846(2):425–38.PubMed Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta. 2014;1846(2):425–38.PubMed
50.
go back to reference Coleman R, Costa L, Saad F, Cook R, Hadji P, Terpos E, Garnero P, Brown J, Body JJ, Smith M, Lee KA, Major P, Dimopoulos M, Lipton A. Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol. 2011;80(3):411–32.PubMedCrossRef Coleman R, Costa L, Saad F, Cook R, Hadji P, Terpos E, Garnero P, Brown J, Body JJ, Smith M, Lee KA, Major P, Dimopoulos M, Lipton A. Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol. 2011;80(3):411–32.PubMedCrossRef
51.
go back to reference Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, Gómez P, Calvo L, Martinez P, Ruiz-Borrego M, Perelló A, Antón A, Codes M, Margelí M, Murias A, Salvador J, Seguí MÁ, de Juan A, Gavilá J, Luque M, Pérez D, Zamora P, Arizcuma A, Chacón JI, Heras L, Martin-Fernández M, Mahillo-Fernández I, Tusquets I. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study). Bone. 2014;68:32–40.PubMedCrossRef Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, Gómez P, Calvo L, Martinez P, Ruiz-Borrego M, Perelló A, Antón A, Codes M, Margelí M, Murias A, Salvador J, Seguí MÁ, de Juan A, Gavilá J, Luque M, Pérez D, Zamora P, Arizcuma A, Chacón JI, Heras L, Martin-Fernández M, Mahillo-Fernández I, Tusquets I. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study). Bone. 2014;68:32–40.PubMedCrossRef
52.
go back to reference Poon M, Zeng L, Zhang L, Lam H, Emmenegger U, Wong E, Bedard G, Lao N, Chow R, Chow E. Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents. Clin Oncol (R Coll Radiol). 2013;25(7):435–44.CrossRef Poon M, Zeng L, Zhang L, Lam H, Emmenegger U, Wong E, Bedard G, Lao N, Chow R, Chow E. Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents. Clin Oncol (R Coll Radiol). 2013;25(7):435–44.CrossRef
53.
go back to reference Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39(1):97–104.PubMedCentralPubMedCrossRef Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39(1):97–104.PubMedCentralPubMedCrossRef
54.
go back to reference Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET. Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev. 2014;40(6):730–8.PubMedCrossRef Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET. Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev. 2014;40(6):730–8.PubMedCrossRef
56.
go back to reference Cummings J, Hacking N, Fairhurst J, Ackery D, Jenkins JD. Distribution of bony metastases in prostatic carcinoma. Br J Urol. 1990;66(4):411–4.CrossRef Cummings J, Hacking N, Fairhurst J, Ackery D, Jenkins JD. Distribution of bony metastases in prostatic carcinoma. Br J Urol. 1990;66(4):411–4.CrossRef
57.
go back to reference D’silva N, Summerline DJ, Cordell KG, Abdelsayed RA, Tomish CE, Hanks CT, Fear D, Meyrowitz S. Metastatic tumors in the jaws. A retrospective study of 114 cases. JADA. 2006;137(12):1667–72.PubMed D’silva N, Summerline DJ, Cordell KG, Abdelsayed RA, Tomish CE, Hanks CT, Fear D, Meyrowitz S. Metastatic tumors in the jaws. A retrospective study of 114 cases. JADA. 2006;137(12):1667–72.PubMed
58.
go back to reference Seoane J, Van der Waal I, Van der Waal RI, Cameselle-Teijeiro J, Antón I, Tardio A, Alcázar-Otero JJ, Varela-Centelles P, Diz P, Antón I, Tardio A, Alcázar-Otero JJ. Metastatic tumours to the oral cavity: a survival study with a special focus on gingival metastases. J Clin Periodontol. 2009;36(6):488–92.PubMedCrossRef Seoane J, Van der Waal I, Van der Waal RI, Cameselle-Teijeiro J, Antón I, Tardio A, Alcázar-Otero JJ, Varela-Centelles P, Diz P, Antón I, Tardio A, Alcázar-Otero JJ. Metastatic tumours to the oral cavity: a survival study with a special focus on gingival metastases. J Clin Periodontol. 2009;36(6):488–92.PubMedCrossRef
59.
go back to reference Otenio CC, Fonseca I, Martins MF, Ribeiro LC, Assis NM, Ferreira AP, Ribeiro RA. Expression of IL-1β, IL-6, TNF-α, and iNOS in pregnant women with periodontal disease. Genet Mol Res. 2012;11(4):4468–78.PubMedCrossRef Otenio CC, Fonseca I, Martins MF, Ribeiro LC, Assis NM, Ferreira AP, Ribeiro RA. Expression of IL-1β, IL-6, TNF-α, and iNOS in pregnant women with periodontal disease. Genet Mol Res. 2012;11(4):4468–78.PubMedCrossRef
60.
go back to reference Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol. 2001;28(9):840–7.PubMedCrossRef Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol. 2001;28(9):840–7.PubMedCrossRef
61.
go back to reference Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9.PubMedCrossRef Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9.PubMedCrossRef
62.
63.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.PubMedCrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.PubMedCrossRef
64.
go back to reference Lim SY, Kim SA, Ahn SG, Kim HK, Kim SG, Hwang HK, Kim BO, Lee SH, Kim JD, Yoon JH. Metastatic tumours to the jaws and oral soft tissues: a retrospective analysis of 41 Korean patients. Int J Oral Maxillofac Surg. 2006;35(5):412–5.PubMedCrossRef Lim SY, Kim SA, Ahn SG, Kim HK, Kim SG, Hwang HK, Kim BO, Lee SH, Kim JD, Yoon JH. Metastatic tumours to the jaws and oral soft tissues: a retrospective analysis of 41 Korean patients. Int J Oral Maxillofac Surg. 2006;35(5):412–5.PubMedCrossRef
65.
go back to reference Nishimura Y, Yakata H, Kawasaki T, Nakajima T. Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg. 1982;10(4):253–8.PubMedCrossRef Nishimura Y, Yakata H, Kawasaki T, Nakajima T. Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg. 1982;10(4):253–8.PubMedCrossRef
66.
go back to reference Shen ML, Kang J, Wen YL, Ying WM, Yi J, Hua CG, Tang XF, Wen YM. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. J Oral Maxillofac Surg. 2009;67(4):718–37.PubMedCrossRef Shen ML, Kang J, Wen YL, Ying WM, Yi J, Hua CG, Tang XF, Wen YM. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. J Oral Maxillofac Surg. 2009;67(4):718–37.PubMedCrossRef
67.
go back to reference Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. 2000;34(1):71–9.PubMedCrossRef Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. 2000;34(1):71–9.PubMedCrossRef
68.
go back to reference Smith SF, Blackman G, Hopper C. Numb chin syndrome: a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(3):e53–6.PubMedCrossRef Smith SF, Blackman G, Hopper C. Numb chin syndrome: a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(3):e53–6.PubMedCrossRef
69.
go back to reference Ahsar A, Khateery SM, Kovacs A. Mandibular metastatic hepatocellular carcinoma: a case involving severe post biopsy hemorrhage. J Oral Maxillofac Surg. 1997;55(6):547–52.CrossRef Ahsar A, Khateery SM, Kovacs A. Mandibular metastatic hepatocellular carcinoma: a case involving severe post biopsy hemorrhage. J Oral Maxillofac Surg. 1997;55(6):547–52.CrossRef
70.
go back to reference Hirshberg A, Leibovich P, Horowitz I, Buchner A. metastatic tumors to post-extraction site. J Oral Maxillofac Surg. 1993;51(12):1334–7.PubMedCrossRef Hirshberg A, Leibovich P, Horowitz I, Buchner A. metastatic tumors to post-extraction site. J Oral Maxillofac Surg. 1993;51(12):1334–7.PubMedCrossRef
71.
go back to reference Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, Roach M 3rd, Briganti A. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2014. doi:10.1016/j.eururo.2014.09.004. Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, Roach M 3rd, Briganti A. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2014. doi:10.​1016/​j.​eururo.​2014.​09.​004.
72.
go back to reference Nakamura T, Ishimaru JI, Mizui T, Kobayashi A, Iwata H, Shimokawa K. Osteosarcoma metastatic to the mandible: a case report. Oral Pathol Oral Radiol Endod. 2001;91(4):452–4.CrossRef Nakamura T, Ishimaru JI, Mizui T, Kobayashi A, Iwata H, Shimokawa K. Osteosarcoma metastatic to the mandible: a case report. Oral Pathol Oral Radiol Endod. 2001;91(4):452–4.CrossRef
73.
go back to reference Bhattacharyya I, Williamson A, Cohen DM, Bever JL. Metastatic neuroblastoma with ganglionuromtous differentiation and mandibular involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(5):582–6.CrossRef Bhattacharyya I, Williamson A, Cohen DM, Bever JL. Metastatic neuroblastoma with ganglionuromtous differentiation and mandibular involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(5):582–6.CrossRef
74.
go back to reference Taylor MB, Bronham NR, Arnold SE. Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines. Br J Radiol. 1014;2012(85):661–71. Taylor MB, Bronham NR, Arnold SE. Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines. Br J Radiol. 1014;2012(85):661–71.
75.
go back to reference National Institute for Health and Clinical Excellence. Diagnosis and management of metastatic disease of unknown primary origin (clinical guideline 104). London UK: National Institute for Health and Clinical Excellence; 2010. National Institute for Health and Clinical Excellence. Diagnosis and management of metastatic disease of unknown primary origin (clinical guideline 104). London UK: National Institute for Health and Clinical Excellence; 2010.
76.
go back to reference Amela EY, Lauridant-Philippin G, Cousin S, Ryckewaert T, Adenis A, Penel A. Management of “unfavourable” carcinoma of unknown primary site: synthesis of recent literarture. Crit Rev Oncol Hematol. 2012;84(2):213–23.PubMedCrossRef Amela EY, Lauridant-Philippin G, Cousin S, Ryckewaert T, Adenis A, Penel A. Management of “unfavourable” carcinoma of unknown primary site: synthesis of recent literarture. Crit Rev Oncol Hematol. 2012;84(2):213–23.PubMedCrossRef
77.
go back to reference Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin: Springer; 2011.CrossRef Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin: Springer; 2011.CrossRef
78.
go back to reference Pavilidis N, Pentheroudokis G. Cancer of unknown primary site. Lancet. 2012;379:1428–35.CrossRef Pavilidis N, Pentheroudokis G. Cancer of unknown primary site. Lancet. 2012;379:1428–35.CrossRef
79.
go back to reference Pepper C, Pai I, Hay A, Deery A, Wilson P, Williamson P, Pitkin L. Investigatin strategy in the management of metastatic adenocarcinoma of unknown primary presenting as cervical lymphadenopathy. Acta Otolaryngol. 2014;134(8):838–42.PubMedCrossRef Pepper C, Pai I, Hay A, Deery A, Wilson P, Williamson P, Pitkin L. Investigatin strategy in the management of metastatic adenocarcinoma of unknown primary presenting as cervical lymphadenopathy. Acta Otolaryngol. 2014;134(8):838–42.PubMedCrossRef
80.
go back to reference Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54(3):243–50.PubMedCrossRef Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54(3):243–50.PubMedCrossRef
81.
go back to reference Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008;32(4):383–9.PubMedCrossRef Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008;32(4):383–9.PubMedCrossRef
82.
go back to reference Shu X, Sundquist K, Sundquist J, Hemminki K. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev. 2012;21(3):281–8.PubMedCrossRef Shu X, Sundquist K, Sundquist J, Hemminki K. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev. 2012;21(3):281–8.PubMedCrossRef
83.
go back to reference Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol. 2014;38(3):227–34.PubMedCrossRef Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol. 2014;38(3):227–34.PubMedCrossRef
84.
go back to reference Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109(5):1318–24.PubMedCentralPubMedCrossRef Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109(5):1318–24.PubMedCentralPubMedCrossRef
85.
go back to reference Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary: a population-based study. Acta Oncol. 2014;53(1):134–7.PubMedCrossRef Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary: a population-based study. Acta Oncol. 2014;53(1):134–7.PubMedCrossRef
86.
go back to reference van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. 2003;41(1):3–6.PubMedCrossRef van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. 2003;41(1):3–6.PubMedCrossRef
87.
go back to reference Thiele OC, Freier K, Bacon C, Flechtenmacher C, Scherfler S, Seeberger R. Craniofacial metastases: a 20-year survey. J Craniomaxillofac Surg. 2011;39(2):135–7.PubMedCrossRef Thiele OC, Freier K, Bacon C, Flechtenmacher C, Scherfler S, Seeberger R. Craniofacial metastases: a 20-year survey. J Craniomaxillofac Surg. 2011;39(2):135–7.PubMedCrossRef
88.
89.
go back to reference Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010;134(2):216–24.PubMed Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010;134(2):216–24.PubMed
90.
go back to reference Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462–9.PubMedCrossRef Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462–9.PubMedCrossRef
91.
go back to reference Epstein JI, Egevad L, Humphrey PA, Montironi R. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e6–19.PubMed Epstein JI, Egevad L, Humphrey PA, Montironi R. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e6–19.PubMed
92.
go back to reference Reuter VE, Argani P, Zhou M, Delahunt B. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e35–49.PubMed Reuter VE, Argani P, Zhou M, Delahunt B. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e35–49.PubMed
93.
go back to reference Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. 2014;141(5):630–8.PubMedCrossRef Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. 2014;141(5):630–8.PubMedCrossRef
94.
go back to reference Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.PubMedCrossRef Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.PubMedCrossRef
Metadata
Title
Metastatic Tumors to the Jaws and Mouth
Authors
Abraham Hirshberg
Raanan Berger
Irit Allon
Ilana Kaplan
Publication date
01-12-2014
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 4/2014
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-014-0591-z

Other articles of this Issue 4/2014

Head and Neck Pathology 4/2014 Go to the issue

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

The Diagnostic Usefulness of Immunohistochemistry for Odontogenic Lesions

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Molecular and Genetic Aspects of Odontogenic Lesions

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Bone- and Cartilage-Forming Tumors and Ewing Sarcoma: An Update with a Gnathic Emphasis

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

An Update on Gnathic Pathology

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Advances in Diagnostic Imaging for Pathologic Conditions of the Jaws

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Osteochemonecrosis: An Overview